CTCs
TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy Platform
The startup's strategic agreements with Genetron Holdings and ARUP Laboratories will accelerate global deployment of its TellDx liquid biopsy platform.
The company has previously offered its liquid biopsy tests through an LDT model but sees the timing and the clinical niche as right for a regulatory bid in CSF testing.
CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test
CellMax also completed a Series C financing round to speed up development of itsFirstSight liquid biopsy test to detect colorectal cancer and precancer polyps.
Scienion, Gilupi to Develop Circulating Tumor Cell Analysis Workflow
The firms plan to build a workflow for CTC isolation directly from a patient's bloodstream for single-cell downstream molecular analysis such as sequencing, genotyping, or digital PCR.
Menarini's CellSearch Shows CTCs' Potential to Predict Breast Cancer Prognosis, Treatment Response
Premium
A meta-analysis showed that early circulating tumor cell dynamics were associated with overall survival using Menarini Silicon Biosystems' CellSearch assay.